Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
NovoCure Limited (NVCR) had Return on Equity of -57.12% for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$509.34M |
|
$-207.04M |
|
$128.28M |
|
$381.06M |
|
$742.21M |
|
$-232.87M |
|
$41.13M |
|
$-191.74M |
|
$-191.74M |
|
$-207.04M |
|
$-207.04M |
|
$-207.04M |
|
$-207.04M |
|
$-232.87M |
|
$-244.99M |
|
106.39M |
|
106.39M |
|
$-1.95 |
|
$-1.95 |
|
| Balance Sheet Financials | |
$1.03B |
|
$62.86M |
|
$111.72M |
|
$1.15B |
|
$179.12M |
|
$568.82M |
|
$604.52M |
|
$783.63M |
|
$362.50M |
|
$362.50M |
|
$362.50M |
|
107.08M |
|
| Cash Flow Statement Financials | |
$-73.34M |
|
$184.15M |
|
$15.79M |
|
$115.83M |
|
$242.56M |
|
$126.73M |
|
$115.61M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.78 |
|
-- |
|
-- |
|
0.61 |
|
1.57 |
|
74.81% |
|
-45.72% |
|
-45.72% |
|
-48.10% |
|
-37.64% |
|
-40.65% |
|
$-100.43M |
|
-- |
|
-- |
|
-- |
|
0.44 |
|
3.36 |
|
6.07 |
|
60.12 |
|
|
Return on Equity |
-57.12% |
-57.12% |
|
-18.06% |
|
-22.23% |
|
$3.39 |
|
$-0.94 |
|
$-0.69 |
|